Literature DB >> 10838716

Prophylactic efficiency of 3-weekly benzathine penicillin G in rheumatic fever.

B Oran1, A Tastekin, S Karaaslan, L Bas, A Ayçiçek, A Ceri, A Sütçü, I Erkul.   

Abstract

Benzathine penicillin G (BPG) is effective for secondary prophylaxis of rheumatic fever (RF). However, interval between injections a remains a controversial matter. In a study population of 74 patients, following the initial diagnosis of RF, 3-weekly BPG (1.2 million units) regimen was started. During the first three-week period, serum penicillin concentrations were examined on the 7th, 14th and 21st days and throat culture done for group-A b hemolytic streptococcal (GABHS) infection. Ten patients (13.5%) at 21st day of injection had low serum penicillin concentration after the first BPG. GABHS was isolated in 5 patients during this period. Although two of these 5 patients had symptoms of respiratory tract infection, according to laboratory data, the other three were accepted as carriers. All 74 patients were then followed-up for rheumatic recurrence (RR) during long-term period (6 to 60 months, mean 25 +/- 5 months). There was no RR among regular (missing no more than one injection a year) group. We concluded that 3-weekly BPG regimen was satisfactory for secondary prophylaxis in RF, even though serum penicillin level was inadequate during the third week in some of the patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10838716     DOI: 10.1007/bf02723652

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  25 in total

1.  WHO programme for the prevention of rheumatic fever/rheumatic heart disease in 16 developing countries: report from Phase I (1986-90). WHO Cardiovascular Diseases Unit and principal investigators.

Authors: 
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

2.  Prophylaxis in patients with rheumatic fever: every three or every four weeks?

Authors:  E M Ayoub
Journal:  J Pediatr       Date:  1989-07       Impact factor: 4.406

3.  Rheumatic fever: the way it was.

Authors:  E F Bland
Journal:  Circulation       Date:  1987-12       Impact factor: 29.690

4.  Outbreak of acute rheumatic fever in northeast Ohio.

Authors:  B Congeni; C Rizzo; J Congeni; V V Sreenivasan
Journal:  J Pediatr       Date:  1987-08       Impact factor: 4.406

5.  Penicillin tolerance in beta-streptococci isolated from patients with tonsillitis.

Authors:  E Grahn; S E Holm; K Roos
Journal:  Scand J Infect Dis       Date:  1987

6.  Efficacy of beta-lactamase-resistant penicillin and influence of penicillin tolerance in eradicating streptococci from the pharynx after failure of penicillin therapy for group A streptococcal pharyngitis.

Authors:  T D Smith; W C Huskins; K S Kim; E L Kaplan
Journal:  J Pediatr       Date:  1987-05       Impact factor: 4.406

7.  Resurgence of acute rheumatic fever.

Authors:  D M Hosier; J M Craenen; D W Teske; J J Wheller
Journal:  Am J Dis Child       Date:  1987-07

8.  Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis.

Authors:  K S Kim; E L Kaplan
Journal:  J Pediatr       Date:  1985-11       Impact factor: 4.406

9.  Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association.

Authors: 
Journal:  JAMA       Date:  1992-10-21       Impact factor: 56.272

10.  Prevention of rheumatic fever. A statement for health professionals by the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association.

Authors:  A S Danjani; A L Bisno; K J Chung; D T Durack; M A Gerber; E L Kaplan; H D Millard; M F Randolph; S T Shulman; C Watanakunakorn
Journal:  Circulation       Date:  1988-10       Impact factor: 29.690

View more
  1 in total

1.  Evaluation of the policy of secondary prevention against rheumatic fever among Egyptian children.

Authors:  Soha M Abd El Dayem; Hala Hamza; Sohair Helal; Azza Mohamed; Heba Hassan
Journal:  Indian Heart J       Date:  2014-11-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.